CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View

  2 weeks ago   
post image
CNMD's Q3 earnings beat estimates on the back of higher revenues and lower costs and expenses.
Ticker Sentiment Impact
AVNS
Neutral
14 %
GMED
Neutral
14 %
CNMD
Somewhat Bullish
35 %